Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7350 p604
21 May 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Contraceptive advice may confuse

New guidance on the advice that health professionals should give to women who have missed some of their oral contraceptive pills may be confusing, claim the authors of a comment published in The Lancet this week.

The new guidance (PDF 75K), issued by the UK Faculty of Family Planning and Reproductive Health Care last month, recommends additional methods of contraception if a woman misses three or more pills containing 30–35µg ethinylestradiol or two or more pills containing 20µg or less. It says that emergency contraception may be required if these pills are missed in the first week of the pack, effectively extending the pill-free interval.

Some health professionals have expressed concern about these new recommendations, say the authors, and point out that women may be unsure if their pills contain oestrogen or how much ethinylestradiol they contain.

They also say that the guidelines do not define how many hours late a pill must be to be classed as “missed”. They suggest that one rule for all doses of pill would be less confusing, with more information provided to women about the risk of extending the pill-free interval.

Toni Belfield, director of information at the Family Planning Association, said: “Our helpline work shows that most women do know what kind of pill they are on, but they may not know the name correctly as often it is not easy to say. Clearly, where information is now relating to women using 20µg ethinylestradiol pills versus 30µg ethinylestradiol pills this demands better communication and information from professionals providing any contraception service.”

Back to Top


©The Pharmaceutical Journal